title: Are circulating gonadotropin isoforms naturally occurring biased agonists? Basic and therapeutic implications.
abstract: The gonadotropins, luteinizing hormone, human chorionic gonadotropin and follicle-stimulating hormone, are key regulators of reproduction. As a result of this function, they have been the focus of research for many years. Isolated or recombinant proteins have been successfully used therapeutically for the treatment of infertility; and, in the case of compounds that block gonadotropin activity, for their potential utility in contraception. Until recently, selective small molecules modulating gonadotropin receptor activity have proven difficult to identify. The gonadotropins are glycoproteins that are released into the plasma as differently glycosylated isoforms and bind to specific G protein-coupled receptors. The degree of glycosylation on the gonadotropins has been shown to be important for the biological activities of these hormones and is differentially regulated depending on the steroidal status. Recent data from the study of glycosylated variants of LH, hCG and FSH have revealed that these isoforms have distinct signaling properties that allow for gonadotropin pleiotropic signals to be transduced effectively at the level of the receptor. Thus, glycosylated variants of the gonadotropins behave as biased agonists. Recently, newly developed, small molecule, synthetic allosteric compounds have been identified that are capable of mimicking this biased signaling. This opens the door to development of orally available, drug-like therapies for reproductive disorders that offer similar pleiotropic richness as that offered by the complex, endogenous hormones.
authors.affiliation: Metabolic and Cardiovascular Drug Discovery, Research and Development, Bristol-Myers Squibb Co., 311 Pennington-Rocky Hill Rd., Mail Stop- 21-1.08, Hopewell, NJ 08543, USA. brian.arey@bms.com
authors.forename: Brian J
authors.initials: BJ
authors.lastname: Arey
authors.forename: Francisco J
authors.initials: FJ
authors.lastname: López
mesh_terms: D000818:Animals; D001688:Biological Products / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D005640:Follicle Stimulating Hormone / Q000819:agonists / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use; D006062:Gonadotropins / Q000819:agonists / Q000097:blood* / Q000494:pharmacology* / Q000627:therapeutic use*; D006801:Humans; D008954:Models, Biological; D020033:Protein Isoforms / Q000819:agonists / Q000097:blood / Q000494:pharmacology / Q000627:therapeutic use; D011967:Receptors, Gonadotropin / Q000819:agonists*; D012106:Research
chemical_list: D001688:Biological Products; D006062:Gonadotropins; D020033:Protein Isoforms; D011967:Receptors, Gonadotropin; D005640:Follicle Stimulating Hormone